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Introduction 
Fibrohistiocytic tumors represent a vast and 
heterogenous group of cutaneous lesions. Plexiform 
fibrohistiocytic tumor (PFHT) is a rare soft tissue 
neoplasm of intermediate malignancy, first 
described by Enzinger and Zhang in 1988 [1] and 




A previously healthy 11-year-old boy was referred to 
our department with a 1-year history of a slowly 
enlarging, asymptomatic cutaneous lesion on his left 
shoulder. Examination revealed a 10mm 
erythematous, well-circumscribed, smooth nodule 
of rubbery consistency, nontender upon palpation 
(Figure 1A). On dermoscopy, a structureless, 
homogenous pink lesion was observed (Figure 1B). 
The remaining physical examination disclosed no 
additional abnormalities. 
An excisional biopsy was performed for both 
diagnostic and therapeutic purposes. Hematoxylin 
and eosin stain revealed a well-circumscribed dermal 
and hypodermal proliferation composed of 
histiocytic-like cells aggregated in nodules, 
surrounded by spindle cell fascicles in a plexiform 
configuration (Figure 2). Through 
immunohistochemical analysis, lesional cells stained 
positive for CD68 and negative for S100 and CD34 
(Figure 3). These features were compatible with a 
diagnosis of PFHT. In the first specimen, the tumor 
extended to the deeper surgical margin. A second 
wider excision was performed, which showed no 
signs of residual neoplasia. The patient remains 
Abstract 
Plexiform fibrohistiocytic tumor is an uncommon soft 
tissue neoplasm of intermediate malignancy, most 
frequently occurring as a painless, slow-growing 
nodule that shows a distinct predilection for children 
and young adults. We report a healthy 11-year-old 
boy presenting with a 1-year history of an 
asymptomatic cutaneous nodule on his left shoulder. 
Histopathological and immunohistochemical 
analysis confirmed a diagnosis of plexiform 
fibrohistiocytic tumor. Despite following a usually 
benign clinical course, this neoplasm is prone to 
frequent local recurrence and occasional metastatic 
ability. It should be considered in the differential 
diagnosis of an enlarging nodule in pediatric 
patients. 
 
Figure 1. A) Solitary, erythematous, smooth nodule on the 
patient’s left shoulder. B) Dermoscopy showed a structureless, 
well-circumscribed homogenous pink lesion. 
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under follow-up, with no evidence of local 
recurrence after 7 months of surveillance. 
 
Case Discussion 
Since the first description of this distinct neoplasm in 
1988, about 200 cases have been reported in the 
literature. Although its age of presentation ranges 
from two months to 77 years [2, 3], PFHT shows a 
distinct predilection for children and young adults, 
with 70% of cases occurring in individuals under 20 
years of age [3]. A congenital origin has been 
described in only very few patients [3-5]. Despite a 
female prevalence being initially suggested, recent 
studies demonstrate a similar distribution between 
genders [2-4]. 
It clinically presents as a painless, solitary, slow-
growing dermal or subcutaneous nodule [1-6] or, 
less frequently, as a firm, indurated plaque [4-6]. In 
rare instances, ulceration can develop [4]. Up to 50% 
of cases occur on the upper extremities, followed by 
the lower extremities, trunk, and head and neck 
regions [1, 5, 6]. Lesions show an indolent clinical 
course and can occasionally remain stable in size for 
several years [3]. 
Diagnosis relies primarily on the unique 
histopathological pattern of PFHT [2]. The neoplasm 
is typically located in the deep dermis, with possible 
extension to the hypodermis and other deeper 
subcutaneous layers [6]. It is composed of two main 
cell populations, arranged in a characteristic 
plexiform configuration. Histiocytic-like cells, 
admixed with multinucleated osteoclast-like giant 
cells, aggregate to form nodules. Fibroblast-like 
spindle cells, on the other hand, are organized in 
fascicles that interconnect adjacent nodules [1, 5]. 
Mild cellular pleomorphism and low mitotic activity 
are commonly observed. However, variants with 
significant cytological atypia are possible, albeit 
infrequently observed [1, 5, 6]. Likewise, vascular 
invasion has been rarely reported [1, 3]. 
Immunohistochemical analysis is useful in 
Figure 3. Immunohistochemical staining demonstrated 
positivity for CD68, 40×. 
Figure 2. Histopathological analysis revealed a dermal and hypodermal neoplasm, with histiocytic-like cells aggregated in nodules, 
surrounded by spindle cell fascicles in a plexiform configuration. H&E, A) 40×. B) 100×. 
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supporting a diagnosis of PFHT. In this regard, 
histiocytic and osteoclast-like cells show a strong 
positivity for CD68, whereas spindle cells express 
smooth muscle actin. Additionally, PFHT cells are 
negative for S100, desmin, cytokeratins, and CD34 [5, 6]. 
The differential diagnosis is vast and must include 
other lesions with a plexiform growth pattern, 
namely fibrous hamartoma of infancy, plexiform 
neurofibroma, plexiform spindle cell nevus, 
fibromatosis (extra-abdominal desmoid), soft tissue 
giant cell tumor, or cellular neurothekeoma [1, 4-6]. 
Surgical excision is the primary reported treatment. 
The local recurrence rate is high and ranges from 
12.5 to 50% in the published literature [4-6], 
reflecting the infiltrative nature of the tumor and the 
consequent difficulty in achieving a complete 
excision [6]. Regional lymph node metastases have 
been reported in 2.4% of cases. Despite its rarity, 
distant dissemination to the lungs has also been 
described in 1.9% of patients [2], having resulted in  
one fatal outcome [4]. At present, no clinical or 
histopathological features of PFHT can reliably 
correlate with its behavior and metastatic capacity 
[1, 5, 6]. Although safety margins have not yet been 
established, wide excision with negative resection 
margins is recommended in all patients, including 
children, to minimize the possibility of recurrence [1, 6]. 
 
Conclusion 
In summary, PFHT is a rare neoplasm that should be 
considered in the differential diagnosis of cutaneous 
nodules in newborns and infants [1]. Regardless of its 
usually benign clinical course, PFHT is prone to 
frequent local recurrence and occasional metastatic 
ability. As such, prompt treatment and a thorough 
long-term surveillance are recommended. 
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